ImmunoPrecise Average Inventory from 2010 to 2025
| HYFT Stock | 1.73 0.08 4.85% |
Average Inventory | First Reported 2010-12-31 | Previous Quarter 6.1 K | Current Value 5.8 K | Quarterly Volatility 527.7 K |
Check ImmunoPrecise Antibodies financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among ImmunoPrecise Antibodies' main balance sheet or income statement drivers, such as Depreciation And Amortization of 5.3 M, Total Revenue of 25.5 M or Gross Profit of 12.1 M, as well as many indicators such as Price To Sales Ratio of 3.2 K, Dividend Yield of 0.0863 or Days Sales Outstanding of 3.5 K. ImmunoPrecise financial statements analysis is a perfect complement when working with ImmunoPrecise Antibodies Valuation or Volatility modules.
ImmunoPrecise | Average Inventory | Build AI portfolio with ImmunoPrecise Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for ImmunoPrecise Stock Analysis
When running ImmunoPrecise Antibodies' price analysis, check to measure ImmunoPrecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunoPrecise Antibodies is operating at the current time. Most of ImmunoPrecise Antibodies' value examination focuses on studying past and present price action to predict the probability of ImmunoPrecise Antibodies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunoPrecise Antibodies' price. Additionally, you may evaluate how the addition of ImmunoPrecise Antibodies to your portfolios can decrease your overall portfolio volatility.